Clinical Trial Update: S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

The phase 1 S0716 trial of vandetanib in combination with docetaxel for patients with advanced solid tumors has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Head and Neck Cancer
• Lung Cancer
• Prostate Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Vandetanib (vandetanib)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Breast Cancer, Head and Neck Cancer | Phase 1 | Status: WITHDRAWN